|
|
Volumn 16, Issue 1, 2012, Pages 56-64
|
|
Update on the management of neuroendocrine tumors: focus on somatostatin antitumor effects.
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOPEPTIN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
CYCLOPEPTIDE;
DRUG DERIVATIVE;
OCTREOTIDE;
SOMATOSTATIN;
ADULT;
ARTICLE;
CARCINOID;
CLINICAL TRIAL (TOPIC);
GASTROINTESTINAL TUMOR;
HUMAN;
NEUROENDOCRINE TUMOR;
NURSE PRACTITIONER;
NURSING;
ONCOLOGY NURSING;
PROSPECTIVE STUDY;
TREATMENT OUTCOME;
ADULT;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
CARCINOID TUMOR;
CLINICAL TRIALS AS TOPIC;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
NEUROENDOCRINE TUMORS;
NURSE PRACTITIONERS;
OCTREOTIDE;
ONCOLOGIC NURSING;
PEPTIDES, CYCLIC;
PROSPECTIVE STUDIES;
SOMATOSTATIN;
TREATMENT OUTCOME;
|
|
EID: 84861669662
PISSN: None
EISSN: 1538067X
Source Type: Journal
DOI: 10.1188/12.CJON.56-64 Document Type: Article |
|
Times cited : (11)
|
|
References (0)
|
